Skip to content

Study · In vitro (cells) · chikungunya virus · 2024

1 result

New Highly Selective Antivirals for Chikungunya Virus identified from the Screening of a Drug-Like Compound Library.

Castro EF, Álvarez DE

Current microbiology4 Sept 2024Cited by 8 (Europe PMC)

PMID39227496 (opens in a new tab)DOI10.1007/s00284-024-03874-8 (opens in a new tab)PepBankPUB-39227496
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In CHIKV reporter-virus laboratory screening, brilacidin was identified as a potential drug candidate against CHIKV.

    In plain wordsIn lab tests, brilacidin was identified as a potential drug candidate against Chikungunya virus.

    Peptide
    Brilacidin
    Outcome
    Not applicableAntiviral screening hit
    Study

    Chikungunya virusn: not reported in source

    fully infectious CHIKV reporter virus screening
    Outcome group
    Antiviral activity · Infection
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Four molecules were identified as potential drug candidates against CHIKV: MMV1634402 (Brilacidin) and MMV102270 (Diphyllin),
    1 context sentence
    Summary · context
    Here, we report the screen of the Pandemic Response Box library of small molecules against a fully infectious CHIKV reporter virus.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.